EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

c-Myc-Induced Therapy Resistance in Leukemia: Mechanisms and Emerging Therapeutic Opportunities

Ali Rafat iD, Javad Arabpour iD, Haniye Yarahmadi, Hediye Khalkhali, Zeinab Mazloumi, Seyyede Sepide Ashraf Moosavi iD, Hossein Kalarestaghi, Khadijeh Dizaji Asl iD, Reza Nejati iD

Medical Sciences · 16.06.2026 · 14 (2) · 325

DOI: 10.3390/medsci14020325 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Medical Sciences, online erschienen am 16.06.2026. Verfasst von Ali Rafat und 8 weiteren Autor:innen. Beteiligte Einrichtung: Anatomical Sciences Research Center, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, Iran. 87159-87411. Hauptthemen laut MEDLINE: Leukemia, Drug Resistance, Neoplasm, Proto-Oncogene Proteins c-myc. Die Arbeit nennt 153 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dysregulation of the c-Myc oncogene is a pivotal event in leukemia pathogenesis and therapy resistance. This review synthesizes current evidence, illustrating that c-Myc drives leukemogenesis by enhancing proliferation, inhibiting apoptosis, and upregulating immune checkpoints like PD-L1. Its overexpression is linked to poor treatment outcomes across various leukemia subtypes. Directly targeting c-Myc remains challenging; however, indirect epigenetic modifiers (BET inhibitors), transcriptional disruption (CDK9 inhibitors), and combination therapies emerge as promising strategies to suppress its oncogenic activity and overcome resistance, paving the way for improved clinical management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LeukemiaDrug Resistance, NeoplasmProto-Oncogene Proteins c-mycHumansAnimalsMolecular Targeted TherapyApoptosis

Stichwörter der Autor:innen

c-Mycleukemialeukemogenesisoncogenetargeted therapytherapy resistance

Substanzen

Proto-Oncogene Proteins c-myc

Autor:innen und Institutionen

  • Anatomical Sciences Research Center, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, Iran. 87159-87411.
  • Department of Biophysics, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran. 14115-154.
  • Department of Microbiology, Faculty of Basic Sciences, Tabriz Branch, Islamic Azad University, Tabriz, Iran. 51579-44511.
  • Department of Medical Applied Cell Sciences, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran. 51579-44511.
  • Student Research Committee, Kashan University of Medical Sciences, Kashan, Iran. 87159-87411.
  • Research Laboratory for Embryology and Stem Cell, Department of Anatomical Sciences, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran. 56189-58911.

ORCID-Profile: Ali Rafat, Javad Arabpour, Seyyede Sepide Ashraf Moosavi, Khadijeh Dizaji Asl, Reza Nejati

Zitieren

APA

Rafat, A., Arabpour, J., Yarahmadi, H., Khalkhali, H., Mazloumi, Z., Ashraf Moosavi, S. S., Kalarestaghi, H., Dizaji Asl, K., & Nejati, R. (2026). c-Myc-Induced Therapy Resistance in Leukemia: Mechanisms and Emerging Therapeutic Opportunities. Medical Sciences, 14(2), 325. https://doi.org/10.3390/medsci14020325

Vancouver

Rafat A, Arabpour J, Yarahmadi H, Khalkhali H, Mazloumi Z, Ashraf Moosavi SS, et al. c-Myc-Induced Therapy Resistance in Leukemia: Mechanisms and Emerging Therapeutic Opportunities. Medical Sciences. 2026;14(2):325. doi:10.3390/medsci14020325

BibTeX
@article{Rafat2026,
  author = {Rafat, Ali and Arabpour, Javad and Yarahmadi, Haniye and Khalkhali, Hediye and Mazloumi, Zeinab and Ashraf Moosavi, Seyyede Sepide and Kalarestaghi, Hossein and Dizaji Asl, Khadijeh and Nejati, Reza},
  title = {c-Myc-Induced Therapy Resistance in Leukemia: Mechanisms and Emerging Therapeutic Opportunities},
  journal = {Medical Sciences},
  year = {2026},
  volume = {14},
  number = {2},
  pages = {325},
  doi = {10.3390/medsci14020325}
}
Kostenlos starten →